◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 1134

Kelfred Holdings Limited (1134) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-08-10

Kelfred Holdings Limited (1134) operates in the Medical Instruments & Supplies industry and is headquartered in Sha Tin, Hong Kong with about 752 employees. Its market capitalization is roughly HKD 130 million. In the fiscal year ended 2025-12-31, 1134 reported HKD 500M in revenue and (HKD 15M) in net income.

Kelfred Holdings Limited, an investment holding company, engages in the manufacture and sale of eyewear products in the People's Republic of China, Italy, the United Kingdom, India, Spain, the Philippines, Hong Kong, France, Japan, Australia, the United States, and internationally.

Interactive charts & full statements →

1134 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueHKD 500MHKD 454MHKD 393MHKD 465M
Gross ProfitHKD 59MHKD 45MHKD 57MHKD 76M
Operating Income (EBIT)(HKD 11M)(HKD 24M)(HKD 13M)HKD 7M
Net Income(HKD 15M)(HKD 22M)HKD 1MHKD 9M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1134 Free Cash Flow History

1134 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsHKD 283MHKD 283MHKD 264MHKD 252M
Total LiabilitiesHKD 134MHKD 126MHKD 81MHKD 65M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1134 viewer.

Other Companies in Medical Instruments & Supplies

← 1133All “0-9” companies1137 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.